Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use†
AbstractDuring the 3rd congress of the European Society of Pharmacogenomics and Personalised Therapy (ESPT) in Budapest in 2015, a preliminary meeting was held aimed at establishing a pediatric individualized treatment in oncology and hematology committees. The main purpose was to facilitate the transfer and harmonization of pharmacogenetic testing from research into clinics, to bring together basic and translational research and to educate health professionals throughout Europe. The objective of this review was to provide the attendees of the meeting as well as the larger scientific community an insight into the compiled evidence regarding current pharmacogenomics knowledge in pediatric oncology. This preliminary evaluation will help steer the committee’s work and should give the reader an idea at which stage researchers and clinicians are, in terms of personalizing medicine for children with cancer. From the evidence presented here, future recommendations to achieve this goal will also be suggested. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 651 KB)
Share & Cite This Article
Mlakar, V.; Huezo-Diaz Curtis, P.; Satyanarayana Uppugunduri, C.R.; Krajinovic, M.; Ansari, M. Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use. Int. J. Mol. Sci. 2016, 17, 1502.
Mlakar V, Huezo-Diaz Curtis P, Satyanarayana Uppugunduri CR, Krajinovic M, Ansari M. Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use. International Journal of Molecular Sciences. 2016; 17(9):1502.Chicago/Turabian Style
Mlakar, Vid; Huezo-Diaz Curtis, Patricia; Satyanarayana Uppugunduri, Chakradhara R.; Krajinovic, Maja; Ansari, Marc. 2016. "Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use." Int. J. Mol. Sci. 17, no. 9: 1502.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.